| abstract |
The invention provides a compound represented by a general formula I, pharmaceutically acceptable salts, enantiomers, diastereoisomers or racemates thereof, a preparation method thereof, a pharmaceutical composition containing the same and application thereof in preparing a medicament for treating diseases or symptoms mediated by EED and/or PRC 2. The compounds of the present invention are useful for treating diseases or conditions mediated by PRC 2. |